enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.55M | -15.72M | -18.82M | -19.47M | -21.97M |
| Total Depreciation and Amortization | 380.00K | 390.00K | 491.00K | 489.00K | 494.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.08M | 2.38M | 3.48M | 3.81M | 4.23M |
| Change in Net Operating Assets | -318.00K | -1.66M | 59.00K | -396.00K | 10.00K |
| Cash from Operations | -13.41M | -14.62M | -14.79M | -15.57M | -17.23M |
| Capital Expenditure | 0.00 | 0.00 | -5.00K | -5.00K | -9.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.35M | 14.27M | 13.43M | 15.86M | 627.00K |
| Cash from Investing | 13.35M | 14.27M | 13.43M | 15.86M | 618.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.10M | 1.15M | 1.02M | 1.02M | 241.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.10M | 1.15M | 1.02M | 1.02M | 241.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.04M | 797.00K | -340.00K | 1.31M | -16.37M |